Search is Powered by Google
Cancer / Oncology News

Latest Research On GI Health Presented At DDW 2008

Main Category: Cancer / Oncology
Also Included In: Conferences;  Liver Disease / Hepatitis;  Obesity / Weight Loss / Fitness
Article Date: 18 May 2008 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

Colonoscopy: New developments in polyp detection, colonoscopy preparation and sedation techniques that will increase the effectiveness of colonoscopy and ease patient concerns about the procedure will be presented. Research advances in sedation include computer-assisted sedation systems and the new evidence supporting the administration of propofol by GI physicians.

Monday, May 19 at Noon Pacific Time
DDW Abstract Numbers: 237, 877, 878, 883, 794, W1420 and a late breaking abstract.

Pancreatic Cancer: New research detailing innovative methods to better understand the risk factors for and improve earlier detection of pancreatic cancer will be presented. Specifically, researchers will demonstrate that the development of new biomarkers, novel treatment targets, innovative approaches to screening and surveillance and improved understanding of risk factors can lead to diagnosis of pancreatic cancer at earlier more treatable stages.

Tuesday, May 20 at 8:00 a.m. Pacific Time
DDW Abstract Numbers: 762, M1431, w1401 and 644.

Imaging & Technology: A sophisticated new surgical technology holds promise for future painless and scarless surgery with shorter recovery times than laparoscopic surgery. New research supports the safety and efficacy of natural orifice translumenal endoscopic surgery (NOTES™ ) and details the outcomes associated with new tools and robotic applications.

Also, a new real-time microscopic technique could change the way gastrointestinal diseases are detected -- confocal laser endomicroscopy (CLE) effectively and immediately identifies suspicious activity and precancerous cells and may eliminate the need in many cases for biopsy in diagnosing gastrointestinal conditions. This could lead to earlier diagnosis and treatment of conditions including reflux disease, colon cancer and irritable bowel disease.

Sunday, May 18 at 8:00 a.m. Pacific Time
DDW Abstract Numbers: 881, SP535, 876, 871, S1162, 673, M1989 and a late breaking abstract.

Liver Disease: Researchers have made great strides in identifying better treatments for liver-related diseases. Results from new investigations into the creation of liver cells from embryonic stem cells; a potential link between recurrent urinary tract infections and primary biliary cirrhosis (PBC); and identification of the most efficacious treatments for patients with hepatitis C will be presented.

Tuesday, May 20 at 11:00 a.m. Pacific Time
DDW Abstract Numbers: 688, W1846, 461 and 161

Obesity: Researchers will unveil new data outlining improved bariatric surgery options and studies that offer new insight into the related toll on the body created by obesity that can cause cancers of the esophagus and pancreas.

Tuesday, May 20 at 1:00 p.m. Pacific Time
DDW Abstract Numbers: 243, M1951, 343 and 484.

NSAIDs: Researchers have begun looking to NSAIDs as having a potential role in the prevention of colorectal cancer, esophageal cancer and pancreatitis. The three studies presented investigate the potentially beneficial role that NSAID medications can play in the treatment of GI-related cancer and in the prevention of surgery-related inflammation.

Sunday, May 18 at Noon Pacific Time
DDW Abstract Numbers: W1625, M1947 and a late breaking abstract.

Celiac Disease: For those suffering from celiac disease, there may be good news on the horizon. New research presented will discuss the latest advancements in the diagnosis and prevention of celiac disease.

Monday, May 19 at 8:00 a.m. Pacific Time
DDW Abstract numbers: 584, 585 and S1263.

Quality of Care and Disparities: Does the success of a procedure depend on how often it is performed at a hospital, or by a particular surgeon" Is a patient's access to procedures such as liver transplantation influenced by patient characteristics such as socioeconomic factors, geographic location, insurance or referral source" These questions and other important quality of care and disparities issues will be discussed via three new research presentations.

Wednesday, May 21 8:00 a.m. Pacific Time
DDW Abstract Numbers: 1033, T1167 and 1874

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

To access DDW research abstracts go to: http://www.ddw.org/press

Digestive Disease Week® 2008 (DDW®) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American

Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 17-22, 2008 in San Diego, Calif. The meeting showcases more than 5,000 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology.

Source: Aimee Frank
Digestive Disease Week




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Understanding And Treating Triple-Negative Breast Cancer
07 Jan 2009
Triple-negative breast cancer is a subtype of breast cancer that is clinically negative for expression of estrogen and progesterone receptors (ER/PR) and HER2 protein. It is characterized by its unique molecular profile...


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Treating HER2+ Breast Cancer image Treating HER2+ Breast Cancer

There are at least four different kinds of breast cancer and each is treated differently. For HER2+ breast cancer, a chemotherapy drug is typically the best option. Here's an overview of the drugs used to treat breast cancer...

View more videos...